Researcher
Leo Heyndrickx
Projects
1 - 3 of 3
- To strengthen Institute of Tropical Medicine Pedro Kouri (IPK, Cuba) and National Institute of Hygiene, Epidemiology and Microbiology (INHEM, Cuba) towards accomplishment of their academic mission through capacity building and scientific co-operation.From1 Jan 2018 → 31 Dec 2018
- Strengthening the capacity for research, teaching, policy advice, advocacy and networking of the partners in the field of human and animal health (South-Africa).From1 Jan 2018 → 31 Dec 2018
- To strengthen the R&D capacities of the Institute of Tropical Medicine Alexander von Humboldt (Peru) to deliver strategies and/or tools for diagnosis, surveillance and control of infectious diseases.From1 Nov 2017 → 31 Dec 2021
Publications
31 - 40 of 130
- Development, evaluation, and integration of a quantitative reverse-transcription polymerase chain reaction diagnostic test for Ebola virus on a molecular diagnostics platform(2016)
Authors: Lieselotte Cnops, Peter Van den Eede, James Pettitt, L Heyndrickx, Birgit De Smet, Sandra Coppens, Ilse Andries, Theresa Pattery, Luc Van Hove, Geert Meersseman, et al.
Pages: S192-S202 - Risk of misinterpretation of Ebola virus PCR results after rVSV ZEBOV-GP vaccination [letter](2015)
Authors: Lieselotte Cnops, Michèle Gerard, Olivier Vandenberg, Sigi Van den Wijngaert, L Heyndrickx, B Willems, Kathy Demeulemeester, Hilde De Clerck, Anne Dediste, Steven Callens, et al.
Pages: 1725-1726 - HIV-1 resistance and trend analysis in newly diagnosed patients in Belgium(2014)
Authors: Gaëtan Muyldermans, Andre Sasse, Katrien Fransen, Annelies Van Den Heuvel, Sergio Garcia Ribas, Leo Heyndrickx
Pages: 1-7 - Protective effect of vaginal application of neutralizing and nonneutralizing inhibitory antibodies against vaginal SHIV challenge in macaques(2014)
Authors: C Moog, N. Dereuddre-Bosquet, J-L Teillaud, M E Biedma, V Holl, G Vanham, Leo Heyndrickx, A Van Dorsselaer, D Katinger, B Vcelar, et al.
Pages: 46-56 - Boosting of HIV-1 neutralizing antibody responses by a distally related retroviral envelope protein(2014)
Authors: Hannes Uchtenhagen, Torben Schiffner, Emma Bowles, Leo Heyndrickx, Celia LaBranche, Steven E Applequist, Marianne Jansson, Thushan De Silva, Jaap Willem Back, Adnane Achour, et al.
Pages: 5802-5812 - Characterization of humoral responses to soluble trimeric HIV gp140 from a clade A Ugandan field isolate(2013)
Authors: M.L. Visciano, M. Tagliamonte, G. Stewart-Jones, Leo Heyndrickx, G Vanham, M. Jansson, A. Fomsgaard, B. Grevstad, M. Ramaswamy, F.M. Buonaguro, et al.
Pages: 1-11 - The N276 glycosylation site is required for HIV-1 neutralization by the CD4 binding site specific HJ16 monoclonal antibody(2013)
Authors: S. Balla-Jhagjhoorsingh, D. Corti, Leo Heyndrickx, Betty Willems, K Vereecken, D. Davis, G Vanham
Pages: e68863 - Selected HIV-1 env trimeric formulations act as potent immunogens in a rabbit vaccination model(2013)
Authors: Leo Heyndrickx, G. Stewart-Jones, M. Jansson, H. Schuitemaker, E. Bowles, L. Buonaguro, B. Grevstad, L. Vinner, K Vereecken, J. Parker, et al.
Pages: e74552 - Diaryltriazine non-nucleoside reverse transcriptase inhibitors are potent candidates for pre-exposure prophylaxis in the prevention of sexual HIV transmission(2013)
Authors: Kevin Ariën, M. Venkatraj, J Michiels, J. Joossens, K Vereecken, P. Van der Veken, Saïd Abdellati, Vicky Cuylaerts, Tania Crucitti, L Heyndrickx, et al.
Pages: 2038-2047 - Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients(2012)
Authors: E. Van Gulck, Lotte BRACKE, L Heyndrickx, Sandra Coppens, D. Atkinson, Céline Merlin, A. Pasternak, Eric Florence, G Vanham
Pages: e37792